biotherapy

(redirected from biotherapies)
Also found in: Medical, Encyclopedia.

bi·o·ther·a·py

 (bī′ō-thĕr′ə-pē)
n. pl. bi·o·ther·a·pies
Treatment of disease with biologics, such as certain drugs, vaccines, or antitoxins.

biotherapy

the treatment of illness and disease with substances derived from living organisms, as vaccines and serums.
See also: Remedies
Translations
Mentioned in ?
References in periodicals archive ?
Dr Cartier-Lacave is a research director at INSERM, where she leads the group "Biotherapies of neurodegenerative diseases." Dr Cartier-Lacave is president of the European Society of Gene and Cell Therapy (ESGCT).
Contract notice: upgrade of a water treatment plant at the center for biology pathology and acquisition of one or two compact water units for dishwashers in the service of biotherapies, maintenance and associated consumables
Be The Match BioTherapies and Cryoport announced a strategic partnership to deliver end-to-end supply chain services to the cell and gene therapy industry.
He has also chaired the start-up Genosafe and launched the Institute of Biotherapies for Rare Diseases.
24 January 2018 - Minnesota, US-based cellular therapy solutions organisation Be The Match BioTherapies has invested in Pennsylvania, US-based clinical-stage biotherapeutics company Tmunity Therapeutics to support advancement of next-generation T cell iummunotherapies, the company said.
Altacor, an ophthalmic product specialist, and NuVision Biotherapies, a regenerative wound treatment company, have announced the signing of a strategic partnership to distribute the sight-saving therapy, Omnigen, in England, Scotland and Wales.
They research, develop, manufacture and market biotherapies, which are used to treat serious and rare conditions, including coagulation (bleeding) disorders such as haemophilia and von Willebrand disease and immune deficiencies.
Poland is the chair of a safety evaluation committee for novel investigational vaccine trials being conducted by Merck, and he offers consultative advice on vaccine development to Merck, CSL Biotherapies, Avianax, Dynavax, Novartis, Emergent BioSolutions, Adjuvance, Microdermis, Seqirus, NewLink, Protein Sciences, GlaxoSmithKline, and Sanofi Pasteur.
"This partnership marks a significant change in how pharmaceutical companies view theranostics and is a formidable opportunity to promote the monitoring of biotherapies. For the first time, a pharmaceutical company will be pairing our monitoring kits with their treatments.
"Although biotherapies are increasingly more sophisticated, the tools for delivering regenerative therapies demonstrate a limited capacity in achieving high cell retention in the heart," said Atta Behfar, a cardiology specialist and lead author of the study.
As a member of the Atlanpole Biotherapies cluster, the company was spun out of the Institute for Transplantation Urology, Nephrology (ITUN, Europe's leading centre for kidney and combined kidney/pancreas transplantation) in December 2007.